The redox‐sensitive Sp family transcription factor has been linked to the regulation of angiotensin
II
type 1 receptor (
AT
1R). However, the exact mechanism of
AT
1R regulation in renal cells is poorly understood. We tested the specificity of reactive oxygen species (
ROS
), superoxide vs. hydrogen peroxide (H
2
O
2
), and the specific role of Sp3 transcription factor, if any, in the regulation of
AT
1R in human kidney cells (
HK
2 cells). Superoxide dismutase (
SOD
) inhibitor diethyldithiocarbamate (
DETC
), but not H
2
O
2
treatment, increased fluorescence levels of superoxide probe dihydroethidium (
DHE
). H
2
O
2,
but not
DETC
, treatment increased the fluorescence of the H
2
O
2
‐sensitive probe dichloro‐dihydro‐fluorescein (
DCFH
). These data suggest that
SOD
inhibition by
DETC
increases the superoxide but not H
2
O
2
and exogenously added H
2
O
2
is not converted to superoxide in renal cells. Furthermore,
DETC
, but not H
2
O
2
, treatment increased nuclear accumulation of Sp3, which was attenuated with the superoxide dismutase (
SOD
)‐mimetic tempol.
DETC
treatment also increased
AT
1R
mRNA
and protein levels that were attenuated with tempol, whereas H
2
O
2
did not have any effects on
AT
1R
mRNA
. Moreover, Sp3 overexpression increased, while Sp3 depletion by si
RNA
decreased, protein levels of
AT
1R. In addition, Sp3 si
RNA
in the presence of
DETC
decreased
AT
1R protein expression. Furthermore,
DETC
treatment increased the levels of cell surface
AT
1R as measured by biotinylation and immunofluorescence studies. Angiotensin
II
increased
PKC
activity in vehicle‐treated cells that further increased in
DETC
‐treated cells, which was attenuated by
AT
1R blocker candesartan and
SOD
‐mimetic tempol. Taken together, our results suggest that superoxide, but not H
2
O
2
, via Sp3 up‐regulates
AT
1R expression and function in the renal cells.